Comprehensive coverage on the latest pharmaceutical regulatory update and industry activities in China.
China Promotes Distribution of Medicare-covered Drugs Through "Double Channel" China permits qualified drug stores to sell prescription drugs included in the National Reimbursement Drug List. At these drug stores, people can enjoy the same medical care payment coverage with hospitals. The policy intends to add another sales channel for the drugs outside hospitals, especially for the newly listed drugs through centralized procurement.
May 24, 2021
China's 2021 Two Sessions: What Can We Expect for the Medical and Health Sectors? Chinese Premier Li Keqiang pointed out nine major objectives in the medical and health sectors in 2021 in the Government Work Report on March 5th.
Mar 15, 2021
China to Carry out National Insulin Procurement China will pilot a nationwide insulin procurement which may refer to the previous pilot insulin procurement scheme in Wuhan. It means the price of insulin products will be significantly reduced, and the market share of relevant pharmaceutical companies in China will be affected.
Mar 08, 2021
Chinese Market Becomes More Intense for Antidiabetic Drugs China's fourth round of national centralized drug procurement has begun, according to the Jinfu Chen, deputy head of the National Healthcare Security Administration in Beijing on Jan. 29, 2021. This time five new diabetes medications are included in the procurement list. They are empagliflozin, canagliflozin, repaglinide, nateglinide, and gliclazide.
Jan 30, 2021
China's 2020 National Reimbursement Drug List Includes 119 Additional Drugs China's National Healthcare Security Administration and the Ministry of Human Resources and Social Security have released the 2020 Edition of the National Reimbursement Drug List (NRDL) on Dec. 28, 2020, which will take effect on Mar. 1, 2021.
Jan 17, 2021
China's Social Medical Insurance to Cover More Drugs for Rare Diseases On Dec. 28, 2020, the National Healthcare Security Administration and Ministry of Human Resources and Social Security issued the 2020 Edition of the National Reimbursement Drug List (NRDL).
Dec 29, 2020
- China DMF Filing, Review & Approval System for APIs, Pharmaceutical Excipients & Packaging Materials
- Introduction to China's COVID-19 Vaccines
- New Market Entry Pathways of Medical Products: Special Medical Zones in China
- China to Pilot Cross-Border E-Commerce Retail Import of Drugs
- Monthly Recap: China Pharmaceutical Regulatory Updates | April 2021